ArticleJournal of cancer research and clinical oncology2025
Associations between MRI radiomics analysis and tumor-micro milieu in uterine cervical cancer.
Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tumor stroma ratio-based radiomics model for predicting platinum resistance and prognosis in epithelial ovarian cancer.Journal of ovarian research · 2026Article
- An interpretable MRI radiomics approach for preoperative prediction of lymphovascular space invasion in cervical cancer using optimal peritumoral region.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe complex interactions of the tumor micromilieu could be reflected by magnetic resonance imaging (MRI) when analyzed with the radiomics approach. For several tumor entities, it has been shown that radiomics derived from MRI can reflect important characteristics of the tumors. The present study investigated the association radiomics derived from MRI images and histopathological features in uterine cervical cancer.
methodsThe MRI before any treatment was used to extract the radiomics features of T1- and T2-weighted images. The biopsy specimens were stained for Ki 67, e-cadherin, vimentin, programmed-death ligand 1, and tumor-infiltrating lymphocytes (TIL, all CD45 positive cells). Tumor-stroma ratio (TSR) was calculated on routine H&E specimen. Spearman's correlation analysis and discrimination analyses were performed as statistical analyses.
resultsThe patient sample was comprised of 89 female patients with a mean age of 49.3 years ± 14.6 (range 27-77 years) with squamous cell cervical carcinoma. "Kurtosis" derived from T1-weighted images after contrast media application correlated with the Ki-67 index (r = 0.28, p = 0.02). "WavEnHL_s-4" derived from T2-weighted images and "S(1.0)Contrast" derived from T1-weighted images after contrast media application showed correlations with TSR (r = - 0.24, p = 0.04, each). Several associations were identified between the radiomics features with immune scores defined by programmed-death ligand 1, the highest correlation showed Teta1 derived from T2-weighted images with the combined positive score (r = - 0.38, p < 0.01). There were several associations with vimentin expression, the highest showed "Variance" derived from T1-weighted images after contrast media application (r = 0.46, p < 0.01).
conclusionsRadiomics features derived from MRI can reflect tumor characteristics of UCC. Especially immune-related features were reflected by the MRI texture features. Proliferation potential, composition of the extracellular matrix and tumor-stroma ratio were also significantly associated with radiomics features. These presented results need to be evaluated in an independent cohort to test their stability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.